MD

MEDNAX
NYSE

Real-time Quotes | Nasdaq Last Sale

31.69
+0.01
+0.03%
Opening 12:15 06/22 EDT
OPEN
31.70
PREV CLOSE
31.68
HIGH
32.00
LOW
31.16
VOLUME
64.97K
TURNOVER
--
52 WEEK HIGH
34.19
52 WEEK LOW
12.47
MARKET CAP
2.73B
P/E (TTM)
185.00
1D
5D
1M
3M
1Y
5Y
Tenet Healthcare (THC) to Divest Hospitals for $1.1 Billion
Zacks.com · 4d ago
Tenet Healthcare (THC) Soars 69% YTD: More Room to Run?
Zacks.com · 6d ago
Community Health (CYH) Soars 111% YTD: More Room to Run?
Zacks.com · 06/09 16:39
Correction: Mizuho Securities Maintains Price Target for Mednax at $30, Reiterates Neutral Rating
MT Newswires · 06/07 16:20
--Mizuho Securities Adjusts Mednax PT to $20 From $30, Maintains Neutral Rating
MT Newswires · 06/07 12:35
Mednax Stock Shows Every Sign Of Being Modestly Overvalued
GuruFocus News · 06/06 08:01
Insider Trends: MEDNAX Insider Continues Selling Trend with Tax Sale
MT Newswires · 06/02 16:24
Frazier Healthcare Partners Closes Oversubscribed $1.4 Billion Growth Buyout Fund
, /PRNewswire/ -- , a leading healthcare-focused investment firm, has closed its 10th dedicated healthcare private equity fund focused on the middle market. Frazier Healthcare Growth Buyout Fund X, L.P. (FHGB X) was oversubscribed and hit its hard cap of ...
PR Newswire - PRF · 05/27 13:01
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MD. Analyze the recent business situations of MEDNAX through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MD stock price target is 27.00 with a high estimate of 35.00 and a low estimate of 14.00.
EPS
Institutional Holdings
Institutions: 383
Institutional Holdings: 102.02M
% Owned: 118.36%
Shares Outstanding: 86.19M
TypeInstitutionsShares
Increased
51
8.76M
New
35
2.15M
Decreased
78
6.74M
Sold Out
28
4.89M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.19%
Healthcare Providers & Services
+0.07%
Key Executives
Non-Executive Chairman/Independent Director
Guy Sansone
Chief Executive Officer/Director
Mark Ordan
Chief Financial Officer/Executive Vice President
C. Marc Richards
Corporate Executive
Roger Hinson
Executive Vice President/General Counsel/Secretary
Dominic Andreano
Executive Vice President
Nikos Nikolopoulos
Senior Vice President/Chief Accounting Officer
John Pepia
Vice President
Kevin Smith
Lead Director/Independent Director
Manuel Kadre
Director
Roger Medel
Independent Director
Karey Barker
Independent Director
Waldemar Carlo
Independent Director
Paul Gabos
Independent Director
Thomas McEachin
Independent Director
Michael Rucker
Independent Director
John Starcher
Independent Director
Shirley Weis
No Data
About MD
MEDNAX, Inc is a provider of physician services, including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. The Company's national network consist of physicians, including over physicians providing neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It also has affiliated physicians providing maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice. Its network also included other pediatric subspecialists, physicians providing pediatric intensive care, pediatric cardiology care, hospital-based pediatric care, pediatric surgical care, pediatric ear, nose and throat and pediatric ophthalmology services.

Webull offers kinds of MEDNAX Inc stock information, including NYSE:MD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MD stock methods without spending real money on the virtual paper trading platform.